"Tyrkisk validerings- og pålidelighedsundersøgelse af Brompton Breathing Pattern Assessment Tool hos astmapatienter" (BPAT-Turkish)
Validerings- og pålidelighedsundersøgelse af den tyrkiske version af Brompton Breathing Pattern Assessment Tool (BPAT) hos personer med astma
The purpose of this study is to evaluate the validity and reliability of the Turkish version of the Brompton Breathing Pattern Assessment Tool (BPAT) in individuals with asthma. This study aims to determine whether the BPAT is a valid and reliable tool for assessing breathing patterns in Turkish-speaking asthma patients. The research question being addressed is: "Is the Turkish version of the BPAT a valid and reliable tool for assessing breathing patterns in individuals with asthma?"
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Detaljeret beskrivelse
This study is designed to assess the validity and reliability of the Turkish version of the Brompton Breathing Pattern Assessment Tool (BPAT). BPAT is a well-established tool used to assess the breathing patterns of individuals with respiratory conditions. In this study, a group of asthma patients will be evaluated using the BPAT to determine its applicability and consistency in the Turkish-speaking population.
The reliability of the tool will be tested through repeated measurements, and its validity will be assessed by comparing BPAT results with other validated asthma assessment tools. The data will be analyzed to evaluate the internal consistency, test-retest reliability, and construct validity of the BPAT in a clinical asthma population.
The linguistic validation process will be conducted following the ISPOR Task Force guidelines, including forward translation, reconciliation, back-translation, and cognitive debriefing. The psychometric properties of the tool, including internal consistency, test-retest reliability, and construct validity, will be evaluated according to the COSMIN checklist standards.
Additionally, participant eligibility will be defined as individuals who are diagnosed with asthma and can understand and respond to questions in Turkish. The study will also explore any cultural adaptations necessary for the Turkish version of the BPAT to ensure its cultural relevance and accuracy in assessments.
Undersøgelsestype
Undersøgelsestype
Tilmelding (Faktiske)
Tilmelding
Kontakter og lokationer
Studiesteder
-
-
Istanbul
-
Istanbul, Istanbul, Tyrkiet (Türkiye), 34844
- Süreyyapaşa Chest Diseases And Thoracic Surgery Training And Research Hospital
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
The participants for this study will be recruited from Health Sciences University, İstanbul Süreyyapaşa Chest Diseases and Chest Surgery Education and Research Hospital in Istanbul, Turkey. Participants will be selected based on the eligibility criteria outlined, including those diagnosed with severe persistent asthma as per the Global Initiative for Asthma (GINA) guidelines. Participants will be recruited from local clinics specializing in respiratory diseases and asthma management.
Beskrivelse
Inclusion Criteria:
- Aged between 18 and 75 years
- Diagnosed with severe persistent asthma according to the Global Initiative for Asthma (GINA) criteria
- Native Turkish speaker
- Ability to read and write in Turkish
- Willingness to participate in the study
Exclusion Criteria:
- Having had a respiratory infection in the last 1 month
- Use of oral corticosteroids in the last 4 weeks
- Presence of malignancy, vasculitis, or pregnancy
- Body Mass Index (BMI) > 35 kg/m2
- Diagnosis of COPD or other primary respiratory diseases (excluding asthma)
- Any musculoskeletal, neurological, or cardiovascular condition that could interfere with breathing pattern assessment or impede potential respiratory physiotherapy applications
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: COHORT
- Tidsperspektiver: PROSPECTIVE
Antal grupper/kohorter
Kohorter og interventioner
Gruppe / kohorteGruppe / kohorte |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Asthma Patients
Individuals aged 18-75, diagnosed with severe persistent asthma according to GINA criteria, who are native Turkish speakers. |
A tool used to assess breathing patterns in asthma patients through clinical observation. A set of validated questionnaires and objective tests used to compare with BPAT results for construct validity |
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Construct Validity of the Turkish Version of the Brompton Breathing Pattern Assessment Tool (BPAT)
Tidsramme: Baseline
|
The study aims to evaluate the construct validity of the Turkish version of the BPAT in assessing breathing patterns among Turkish-speaking asthma patients. Validity will be determined by calculating correlation coefficients (e.g., Spearman's or Pearson's r) between the total BPAT scores, objective physiological measures (spirometry results such as FEV1 and FVC), and the scores of established reference clinical tools (Nijmegen Questionnaire, Dyspnea-12, Asthma Control Test (ACT), and Asthma Quality of Life Questionnaire (Mini-AQLQ). |
Baseline
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Test-Retest Reliability of the Turkish Version of BPAT
Tidsramme: 7 to 14 days
|
This outcome will assess the test-retest reliability of the Turkish version of BPAT by measuring the consistency of the tool in repeated assessments. The BPAT will be administered twice to the same participants. Reliability will be evaluated by calculating the Intraclass Correlation Coefficient (ICC). |
7 to 14 days
|
|
Inter-Rater Reliability of the Turkish Version of BPAT
Tidsramme: Baseline
|
This outcome will assess the inter-rater reliability of the Turkish version of BPAT. Two independent physiotherapists will evaluate the breathing pattern of the same asthma patient. The raters will be blinded to each other's scores to determine the consistency of the tool's application between different users. Reliability will be evaluated by calculating the Intraclass Correlation Coefficient (ICC) or Cohen's Kappa. |
Baseline
|
|
Comparison of BPAT Results with Other Asthma Assessment Tools
Tidsramme: Baseline
|
Description: This outcome will compare the BPAT results with other validated asthma assessment tools, such as Nijmegen Questionnaire, Dyspnea-12 Questionnaire , spirometry, ACT (Asthma Control Test), and Mini AQLQ (Asthma Quality of Life Questionnaire), to determine the congruence between different assessment methods. |
Baseline
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Samarbejdspartnere
Samarbejdspartnere
Efterforskere
Efterforskere
- Ledende efterforsker: Zuhal Kunduracılar, Prof., Istanbul Gelisim University
- Studiestol: Fatma M. Tepetam, Prof., Saglik Bilimleri Universitesi
- Studiestol: Şeyma Ozden, Dr., Saglik Bilimleri Universitesi
- Ledende efterforsker: Dilek Unsal, PT PhD(c), Saglik Bilimleri Universitesi
- Studiestol: Nisanur Tutus, PT Phd (c), Saglik Bilimleri Universitesi
Publikationer og nyttige links
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Studiestart
Primær færdiggørelse (Faktiske)
Primær færdiggørelse
Studieafslutning (Faktiske)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- 25/428
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
Individual participant data will not be publicly shared in order to protect patient confidentiality and comply with the local ethics committee regulations. However, completely anonymized data may be made available upon reasonable academic request to the Principal Investigator following the publication of the study results.
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .